International Health
Volume 2, Issue 1 , Pages 36-41 , March 2010

Referral success among HIV-infected women and HIV-exposed children referred for monitoring and treatment in Tanga, Tanzania

  • Anne Arreskov

      Affiliations

    • Department of Infectious Diseases, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark
    • ,
  • Edith Minja

      Affiliations

    • Bombo Regional Hospital, Tanga, Tanzania
    • ,
  • Zahra Theilgaard

      Affiliations

    • Department of Infectious Diseases, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark
    • ,
  • Celine Mandara

      Affiliations

    • National Institute for Medical Research, Tanga Medical Research Centre, Tanga, Tanzania
    • ,
  • Jan Gerstoft

      Affiliations

    • Department of Infectious Diseases, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark
    • ,
  • Martha Lemnge

      Affiliations

    • National Institute for Medical Research, Tanga Medical Research Centre, Tanga, Tanzania
    • ,
  • Terese L. Katzenstein

      Affiliations

    • Department of Infectious Diseases, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark
    • Corresponding Author InformationCorresponding author. Tel.: +45 35451492; fax: +45 35456648.

Received 2 July 2009 ,Revised 8 November 2009 ,Accepted 22 December 2009.

References 

  1. UNAIDS. HIV prevalence in Tanzania. http://www.unaids.org/en/CountryResponses/Countries/united_republic_of_tanzania.asp (accessed 10 June 2009).
  2. Wagner G, Ryan G, Taylor S. Formative evaluation of antiretroviral therapy scale-up efficiency in sub-Saharan Africa. AIDS Patient Care STDS. 2007;21:871–888
  3. ClinicalTrials.gov. ComTru study. http://clinicaltrials.gov/ct2/show/NCT00346567?cntry1=AF%3ATZ&rank=38 (accessed 10 June 2009).
  4. UNAIDS. Tanzania National Guidelines, 2007. http://www.unaids.org/en/CountryResponses/Countries/united_republic_of_tanzania.asp (accessed 10 June 2009).
  5. WHO/UNAIDS/UNICEF. Joint WHO/UNAIDS/UNICEF statement on use of cotrimoxazole as prophylaxis in HIV exposed and HIV infected children. http://www.who.int/3by5/mediacentre/en/Cotrimstatement.pdf (accessed 10 June 2009).
  6. Wikipedia contributors. Tanga, Tanzania. Wikipedia, The Free Encyclopedia. http://en.wikipedia.org/wiki/Tanga,_Tanzania (accessed 10 June 2009).
  7. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4:e298
  8. Wang B, Losina E, Stark R, Munro A, Walensky R, Wilke M, et al. Loss to follow-up in community clinics in South Africa: role of CD4 count, gender and pregnancy. 15th Conference on Retroviruses and Opportunistic Infections; 3-6 February 2008; Boston, MA. CROI 2008; Abstract # 841. http://retroconference.org/2008/Abstracts/32062.htm (accessed 10 June 2009).
  9. Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, Schouten EJ, et al. True outcomes for patients on antiretroviral therapy who are “lost to follow-up” in Malawi. Bull World Health Organ. 2007;85:550–554
  10. Karcher H, Omondi A, Odera J, Kunz A, Harms G. Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Trop Med Int Health. 2007;12:687–694
  11. Cantrell RA, Sinkala M, Megazinni K, Lawson-Marriott S, Washington S, Chi BH, et al. A pilot study of food supplementation to improve adherence to antiretroviral therapy among food-insecure adults in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2008;49:190–195
  12. Zachariah R, Teck R, Buhendwa L, Fitzerland M, Labana S, Chinji C, et al. Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district in Malawi. Trans R Soc Trop Med Hyg. 2007;101:79–84
  13. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359:2233–2244
  14. Manzi M, Zachariah R, Teck R, Buhendwa L, Kazima J, Bakali E, et al. High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling-up requires a different way of acting. Trop Med Int Health. 2005;10:1242–1250
  15. Sherman GG, Jones SA, Coovadia AH, Urban MF, Bolton KD. PMTCT from research to reality—results from a routine service. S Afr Med J. 2004;94:289–292
  16. Zachariah R, Harries AD, Luo C, Bachman G, Graham SM. Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries. Lancet Infect Dis. 2007;7:686–693
  17. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008;86:559–567
  18. Mshana GH, Wamoyi J, Busza J, Zaba B, Changalucha J, Kaluvya S, et al. Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS. 2006;20:649–657
  19. Brou H, Djohan G, Becquet R, Allou G, Ekouevi DK, Viho I, et al. When do HIV-infected women disclose their HIV status to their male partner and why? A study in a PMTCT programme. Abidjan. PLoS Med. 2007;4:e342
  20. Dahab M, Charalambous S, Hamilton R, Fielding K, Kielmann K, Churchyard GJ, et al. “That is why I stopped the ART”: patients’ & providers’ perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. BMC Public Health. 2008;8:63
  21. Theilgaard Z, Arreskov A, Chiduo M, Bakari V, Gerstoft J, Bygbjerg I, Katzenstein T. Referral—a crucial sted towards uptake of HAART. Overcoming the crisis of TB and AIDS. Keystone Symposia, Global Health series; 20–25 October 2009; Arusha, Tanzania. Abstract 332.

PII: S1876-3413(10)00003-3

doi: 10.1016/j.inhe.2009.12.010

International Health
Volume 2, Issue 1 , Pages 36-41 , March 2010

Article Tools

* Image Usage & Resolution